Alx Oncology Holdings (ALXO) Shares Outstanding (2019 - 2026)

Alx Oncology Holdings has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $104.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 95.89% year-over-year to $104.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.6 million (up 95.89% YoY) and the FY2025 annual result came in at $54.4 million, up 2.52% from the prior year.
• Shares Outstanding (Entity) rose to $104.6 million in Q1 2026 per ALXO's latest filing, from $54.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $104.6 million in Q1 2026 and troughed at $40.7 million in Q1 2022.
• A 5-year average of $50.8 million and a median of $50.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) rose 0.51% in 2023, then soared 95.89% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $40.9 million in 2022, then gained by 22.25% to $50.0 million in 2023, then grew by 6.21% to $53.1 million in 2024, then increased by 2.52% to $54.4 million in 2025, then jumped by 92.27% to $104.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $104.6 million, $54.4 million, and $53.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.